Tumor Immunotherapy
The Tumor Microenvironment
Receptor Downregulation in MVBs
Cytotoxic T Cells-mediated Immune Response
Inflammatory Response
mTOR Signaling and Cancer Progression
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Guijun Liu1, Xuxiao He1, Gaoxiang Zhao2
1Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310029, China; Institute of Fundamental and Transdisciplinary Research, Zhejiang University, Hangzhou, Zhejiang 310029, China; Zhejiang University Cancer Center, Hangzhou, Zhejiang 310029, China.
The complement system aids immune responses against pathogens and damaged cells. In tumors, it can paradoxically promote immune evasion and cancer progression.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: